 |
humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin (IL)-23 |
|---|---|
| Trade Name | |
| Orphan Indication | pediatric Crohn’s disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-06 00:00:00 |
| Sponsor | Eli Lilly & Company;Lilly Corporate Center;Indianapolis, Indiana, 46285 |
